Puma Biotechnology, Inc. (PBYI) Reports Q3 Loss of $1.29
Puma Biotechnology, Inc. (: PBYI) reported Q3 EPS of ($1.29), versus ($0.09) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $0 .
For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.
For earnings history and earnings-related data on Puma Biotechnology, Inc. (PBYI) click here.
